Sign in

CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company

Ernexa Therapeutics Inc.

Sign in to watch
Ticker
ERNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
311103425
Phone
(617) 798-6700
Business address
1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
Former names
Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC

Securities

  • ERNA Common Stock Nasdaq
  • ERNAW Warrants Nasdaq
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 8-K Event Exit or restructuring costs
  6. 8-K Event Executive or director change
  7. 4 Derivatives Options or other derivatives
  8. 4 Other acquisition Director acquired 92 shares (other)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. EFFECT Other Notice of Effectiveness
  12. 424B3 Offering Prospectus
  13. 8-K Event Other events
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. S-1/A Offering Registration Statement
  16. UPLOAD Other SEC-generated Letter
  17. S-1 Offering Registration Statement
  18. RW Other RW
  19. 8-A12B/A Other Registration Statement
  20. 10-Q Report Quarterly Report

Page 16 of 77 · 1,525 filings